EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Free Report) shares dropped 0.3% on Thursday . The company traded as low as $0.10 and last traded at $0.15. Approximately 605 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 9,457 shares. The stock had previously closed at $0.16.
EOM Pharmaceuticals Trading Down 0.3 %
The company’s 50 day moving average price is $0.15 and its 200-day moving average price is $0.15.
About EOM Pharmaceuticals
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.
Read More
- Five stocks we like better than EOM Pharmaceuticals
- Bank Stocks – Best Bank Stocks to Invest In
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Top 3 Beverage Stocks Pouring Out Profits
- Stock Splits, Do They Really Impact Investors?
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
